| 25682-001 |
SOLIRIS |
ECULIZUMAB |
Alexion Pharmaceuticals Inc. |
INJECTION, SOLUTION, CONCENTRATE |
|
2007-04-02 |
| 25682-022 |
Ultomiris |
ravulizumab |
Alexion Pharmaceuticals Inc. |
SOLUTION, CONCENTRATE |
|
2018-12-21 |
| 25682-025 |
Ultomiris |
ravulizumab |
Alexion Pharmaceuticals Inc. |
SOLUTION, CONCENTRATE |
|
2020-10-09 |
| 25682-028 |
Ultomiris |
ravulizumab |
Alexion Pharmaceuticals Inc. |
SOLUTION, CONCENTRATE |
|
2020-10-09 |
| 50474-990 |
ZILBRYSQ |
zilucoplan |
UCB, Inc. |
INJECTION, SOLUTION |
|
2024-01-03 |
| 50474-991 |
ZILBRYSQ |
zilucoplan |
UCB, Inc. |
INJECTION, SOLUTION |
|
2024-01-03 |
| 50474-992 |
ZILBRYSQ |
zilucoplan |
UCB, Inc. |
INJECTION, SOLUTION |
|
2024-01-03 |
| 51759-208 |
EPYSQLI |
Eculizumab-aagh |
Teva Pharmaceuticals USA, Inc. |
INJECTION, SOLUTION |
|
2025-04-07 |
| 55513-180 |
BKEMV |
eculizumab-aeeb |
Amgen Inc |
INJECTION, SOLUTION, CONCENTRATE |
|
2025-03-01 |
| 61755-014 |
VEOPOZ |
Pozelimab |
Regeneron Pharmaceuticals, Inc. |
INJECTION, SOLUTION |
|
2023-08-18 |
| 73606-010 |
Empaveli |
Pegcetacoplan |
Apellis Pharmaceuticals, Inc. |
INJECTION, SOLUTION |
|
2021-05-14 |
| 73606-020 |
Syfovre |
Pegcetacoplan |
Apellis Pharmaceuticals, Inc. |
INJECTION, SOLUTION |
|
2023-02-17 |